Global Genes

Empowering the Next Generation Rare Disease Advocate. Global Genes and RARE-X officially merged into one organization December 2022 under the name Global Genes. Both organizations have been working toward the goal of empowering the next generation advocate both through their individual initiatives and their strategic partnership announced in 2021. In fact, RARE-X was born out of Global Genes after discussions with advocacy leaders, board members, partners, patients, and care partners, addressing a significant gap in access to tools, technology, and infrastructure. Were Hiring! Check out our open positions at https://globalgenes.org/about-us/career-opportunities

Rare disease awareness,public and physician education,supporting research initiatives,patient advocacy,rare disease,undiagnosed patient program,education,genetics,events,programs,resources,connect,empower,inspire,foundationalliances,and corporatealliances

Global genes operates in the Non-profit organizations industry.

Global genes's revenue is 11m - 100m

Global genes has 11 - 50 employees.